Veterinary Practice News Letter From The Editor: February 2011
I hate cancer.
My cocker spaniel died last summer from liver cancer. According to the Morris Animal Foundation, one in four dogs dies of cancer, all kinds of cancers: osteosarcoma, lymphoma, nasal cancer, transitional cell carcinoma.
And years ago, my male cocker spaniel got a diagnosis of mammary cancer. Luckily, I noticed the growth very early and it never recurred.
So news of AB Science USA’s receiving conditional approval for its Kinavet-CA1 (masitinib) treatment for canine mast cell tumors was welcomed by those of us who have loved dogs with this cancer. It’s a good addition to our armamentarium.
Dr. Albert Ahn, president of AB Science USA in Short Hills, N.J., has been waiting for FDA approval for what must seem like half of forever. (See our cover story for details.)
“It’s been a long time coming,” he told me in early January. “We’ve been ramping up, and the first bottles should be delivered this month.”
I hate the human varieties of cancer as well as the animal ones.
Over the recent holidays, Facebook postings made it clear that many friends and acquaintances were enduring the festivities without loved ones who had been lost to the disease.
In fact, a former colleague here at BowTie Inc., Moira C. (Harris) Reeve, passed on Christmas Eve morning. She was a longtime editor of Horse Illustrated magazine.
Many people, of course, are living with cancer.
Shortly after Thanksgiving, my sister learned she has breast cancer. I faced the same diagnosis in 1991.
The statistics can be staggering. But as AB Science has shown, progress in fighting cancer is being made all the time, and there is hope.
I still hate cancer. But as my sister gets ready for her third round of chemotherapy, I’ll add a more upbeat thought: Bald is beautiful, and playing with wigs can be fun.
Congrats to AB Science. Let’s keep fighting the good fight.
Marilyn Iturri, Editor